circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer
Yuting Sang(Qilu Hospital of Shandong University), Qifeng Yang(Qilu Hospital of Shandong University), Hanwen Zhang(Dongguan People’s Hospital), Chen Li(Central South University), Ning Zhang(Tianjin Children's Hospital), Ying Liu(Qilu Hospital of Shandong University), Bing Chen(Shanghai Medical College of Fudan University), Tong Chen(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Yaming Li(Qilu Hospital of Shandong University), Xiaojin Song(Qilu Hospital of Shandong University), Wenjing Zhao(Xinjiang Uygur Autonomous Region Product Quality Supervision and Inspection Institute), Lijuan Wang(Pingdingshan University), Yiran Liang(Qilu Hospital of Shandong University), Dianwen Han(Qilu Hospital of Shandong University)
Cited by 513
Related Papers
Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets
|Seminars in Cancer Biology|2019|1k
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934
m6A RNA Methylation Is Regulated by MicroRNAs and Promotes Reprogramming to Pluripotency
|Cell stem cell|2015|553
RETRACTED ARTICLE: LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis
|Molecular Cancer|2020|396
Roles and mechanisms of exosomal non-coding RNAs in human health and diseases
|Signal Transduction and Targeted Therapy|2021|389